Potluck

In August 2026, Potluck’s category mix tilted further toward value-driven formats as Flower held 58.69% share with year-over-year decline of 0.05% and month-over-month decline of 9.35%, while Pre-Roll rose to 32.26% share with year-over-year growth of 19.29% and month-over-month growth of 3.51%. Vapor Pens expanded to 8.52% share on year-over-year growth of 47.46% and month-over-month growth of 53.52%, whereas Capsules contracted to 0.28% share with year-over-year decline of 63.26% and month-over-month decline of 36.22%. Tincture & Sublingual remained marginal at 0.25% share with year-over-year decline of 37.14% but month-over-month growth of 28.26%. With average price down 5.08% year-over-year alongside total brand sales up 7.87% year-over-year and up 51.89% over 24 months, the pattern implies Potluck is trading consumers into lower-priced, higher-velocity formats, reducing reliance on Flower while scaling Pre-Roll and Vapor Pens volume.

These shifts reposition Potluck within inhalables by balancing Flower’s scale against faster-growing Pre-Roll and Vapor Pens, which together now comprise 40.78% of mix as of August 2026 versus Flower’s 58.69%, implying a hedged exposure if Flower’s rank at 14 in Ontario weakens or improves. The month-over-month decline of 9.35% in Flower alongside a 53.52% surge in Vapor Pens indicates consumers are migrating to convenient or novelty-driven options, while the 3.51% month-over-month gain in Pre-Roll supports basket diversification instead of pure trade-down. The collapse in Capsules (down 63.26% year-over-year) juxtaposed with a 28.26% month-over-month lift in Tincture & Sublingual suggests Potluck is pruning non-core wellness formats but still testing targeted niches; the implication is a positioning concentrated on quick-turn inhalables with selective experimentation, using price elasticity (average price down 5.08%) to defend share and improve throughput in channels where rank pressure in Flower persists.